Solos Endoscopy Completes Stage 2 of its ISO 1348
Post# of 1609
Posted On: 08/22/2013 2:50:47 PM
Solos Endoscopy Completes Stage 2 of its ISO 13485 Audit with TUV SUD America
Aug 22, 2013 (ACCESSWIRE via COMTEX) -- BOSTON, MA, August 22, 2013 - (Accesswire) - Solos Endoscopy, Inc. (OTCPink: SNDY) is pleased to announce that TUV SUD America has completed its Stage 2 ISO 13485 Audit with Solos Endoscopy on August 16, 2013. Solos Endoscopy will be certified to ISO 13485:2003, the internationally-recognized standard for quality systems for medical device manufacturers, once it reviews and resolves any corrective actions that were discovered during the final audit.
http://www.otcmarkets.com/stock/SNDY/filings
http://www.otcmarkets.com/stock/SNDY/news
blueskies and good luck longs
LIEHUB NEED NOT APPLY!!
Aug 22, 2013 (ACCESSWIRE via COMTEX) -- BOSTON, MA, August 22, 2013 - (Accesswire) - Solos Endoscopy, Inc. (OTCPink: SNDY) is pleased to announce that TUV SUD America has completed its Stage 2 ISO 13485 Audit with Solos Endoscopy on August 16, 2013. Solos Endoscopy will be certified to ISO 13485:2003, the internationally-recognized standard for quality systems for medical device manufacturers, once it reviews and resolves any corrective actions that were discovered during the final audit.
Solos Endoscopy will work with TUV SUD America and Expert Resources to complete the certification to ISO 13485:2003, which will in turn facilitate Solos Endoscopy obtaining the CE Mark on its MammoView[R] devices to sell the MammoView[R] in the European Union. ISO 13485:2003 certification is also a necessary for the company to sell the MammoView[R] product line in Canada. The Company expects the entire process to be concluded by the end of the year, which will allow the Company to market and sell its instruments internationally in 2014.
http://www.otcmarkets.com/stock/SNDY/filings
http://www.otcmarkets.com/stock/SNDY/news
blueskies and good luck longs
LIEHUB NEED NOT APPLY!!
(0)
(0)CYduct Diagnostics Inc. (CYDX) Stock Research Links
Scroll down for more posts ▼